GlassScriptPhysician profile
Thomas Alexander
NPI 1033191838
$94,906.76
in general payments reported to CMS, 2019-2025
52 companies · $6,253 in 2025
The $6,253 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $9,088 · 2021: $17K · 2022: $19K · 2023: $5,916 · 2024: $2,828 · 2025: $6,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,885 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Education: $39.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,773.50 |
| Travel and Lodging | $3,884.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Education | $39.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $62,861.80 | 2019-2024 | Xarelto |
| Medtronic, INC. | $11,235.21 | 2021-2025 | Corevalve Evolut R, Abre, Valiant Captivia |
| Boston Scientific Corporation | $3,210.12 | 2019-2025 | Avvigo Guidance System, Cds - Mct/Cem Monitoring, Watchman Access System |
| Medtronic Vascular, INC. | $2,479.91 | 2019-2020 | |
| Abbott Laboratories | $2,394.01 | 2020-2025 | Cardiomems, Navitor, Pressurewire |
| Nuvasive, INC. | $2,196.66 | 2022 | |
| Penumbra, INC. | $2,174.18 | 2025 | Indigo System, Penumbra System |
| Abiomed | $1,237.93 | 2019-2025 | Impella |
| Merck Sharp & Dohme LLC | $835.73 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $687.72 | 2019-2025 | Opsumit, Uptravi |
| Silk Road Medical, INC. | $657.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $639.97 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $461.40 | 2020-2025 | Farxiga, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $387.55 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $240.74 | 2020-2025 | Repatha, Repatha |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $237.67 | 2019-2022 | |
| Heartflow, INC. | $233.35 | 2021-2025 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.70 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $205.97 | 2023-2024 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $194.75 | 2022-2025 | |
| Pfizer INC. | $188.40 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $168.41 | 2021-2022 | |
| Ekos Corporation | $151.95 | 2019 | |
| Cook Medical LLC | $147.12 | 2024 | Zenith |
| Esperion Therapeutics, INC. | $134.83 | 2020-2021 | |
| Novo Nordisk INC | $116.24 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Scientific Affairs, LLC | $112.81 | 2023 | Xarelto |
| Biotronik INC. | $106.37 | 2022 | |
| Teleflex LLC | $85.44 | 2023-2025 | Manta, Trapliner |
| Chiesi USA, INC. | $80.48 | 2021-2023 | Cleviprex, Kengreal |
| Angiodynamics, INC. | $76.39 | 2019-2020 | |
| Osprey Medical INC | $75.00 | 2019 | |
| Celonova Biosciences, INC. | $67.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.25 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $59.97 | 2019-2024 | |
| Shockwave Medical, INC | $57.71 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $53.62 | 2019-2020 | |
| Cardiva Medical, INC. | $48.93 | 2019 | |
| Edwards Lifesciences Corporation | $48.67 | 2019-2025 | Sapien 3 Ultra Resilia |
| United Therapeutics Corporation | $40.38 | 2019-2021 | |
| Gilead Sciences, INC. | $28.08 | 2019 | |
| Daiichi Sankyo INC. | $27.29 | 2023 | Injectafer |
| Acist Medical Systems, INC. | $25.00 | 2021 | |
| Cardiovascular Systems INC. | $24.55 | 2022 | |
| Baxter Healthcare | $21.41 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $20.58 | 2024 | |
| Daxor Corporation | $19.44 | 2024 | Bva-100 |
| Medtronic USA, INC. | $18.72 | 2019 | |
| Cvrx, INC. | $17.41 | 2025 | Barostim Neo System |
| Acarix USA INC. | $14.84 | 2025 | Cadscor System |
| Inari Medical, INC. | $14.74 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $13.84 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.